cdmo.directory
← Compare landing

Burrard Pharmaceuticals vs OMISAN S.p.A.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/burrardpharma/omisan

CategoryBurrard PharmaceuticalsOMISAN S.p.A.
Listed sitecdmocdmo
SummaryVancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005.Italian maker of sterile ophthalmic medical devices, including eye drops, sprays, eyewashes, and contact lens solutions. Offers private label and CDMO manufacturing for ophthalmic multinationals, with preservative-free dispensing technologies.
Services
  • Technology Transfer
  • Formulation Development
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Process Development
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Oral Solid Dosage Manufacturing
  • Ophthalmic Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Secondary Packaging & Labeling
  • Cold-Chain Storage & Logistics
  • Serialization & Track-and-Trace
  • Ophthalmic Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Metabolic
  • Respiratory
  • Ophthalmology
Locations
  • Headquarters, Vancouver, British Columbia, Canada
  • Headquarters, Guidonia Montecelio, RM, Italy
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.